ACCREDITATION STATEMENT AND CREDIT DESIGNATION

European Accreditation Council for Continuing Medical Education (UEMS/EACCME)

The AD/PD™ 2024 International Conference on Alzheimer’s and Parkinson’s Diseases, Lisbon, Portugal has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 35.5 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. The EACCME is an institution of the European Union of Medical Specialists (UEMS): www.uems.eu

American Medical Association (AMA)

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at https://www.ama-assn.org/education/ama-pra-credit-system/agreement-european-union-medical-specialties-uems

Royal College of Physicians and Surgeons of Canada

Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada. For more information, visit: http://www.royalcollege.ca/rcsite/cpd/providers/international-accreditation-agreements-e

Credit Breakdown  

Each participant should claim only those hours of credit that he/she actually spent in the educational activity.  

Educational Objectives

After attending this event, participants should be able to:

• Address individual needs in compliance with their Continuous Professional Development (CPD) plan
• Enhance dialogue with clinical investigators and basic scientists, as well as established investigators and young upcoming talents
• Assess the impact of COVID-19 on neurodegenerative diseases
• Evaluate the most recent research in treatment development and emerging therapeutic targets in Alzheimer’s disease
• Describe current developments in the treatment of Parkinson’s disease and related neurological disorders
• Evaluate the novel approaches to disease-modifying therapies for Parkinson’s disease
• Discuss common features of neurodegenerative diseases
• Evaluate the most recent advances in drug development and clinical trials in Neurogenerative diseases

Target Audience

The International Conference on Alzheimer’s and Parkinson’s Diseases is the global meeting place for international medical and scientific professionals worldwide engaged in the neurodegeneration field, from basic scientists to clinical investigators, and from established leaders to young upcoming talents. Because of the diverse, clinically focused educational offering, participants can tailor the curriculum to meet the needs of international clinicians of all levels of experience.

To Receive Your CME/CPD Certificate

The CME/CPD certificate will be available after completing the online evaluation and credit claiming procedure. The process takes about 5 minutes. We thank you for your feedback as it is an important part of CME/CPD accreditation and helps improve future educational offerings. 

Before June 9, 2024:
1. Login to the AD/PD™ Education Portal OR register first if you don’t have an account.*
* register using the same email address as your AD/PD™ Conference registration.
* make sure to select “Neurology” as your main field of interest.

2. Once logged in, go to “Online Learning”, and click on the CME/CPD certificate banner on the landing page.
3. Complete the anonymous online evaluation.
4. Complete the credit claim form and submit it.
5. The CME/CPD certificate will be available for download; retain it for your personal records.

Kindly note that the AD/PD™ 2024 online evaluation will be active on the last day of the meeting. You will then be able to access it and claim your CME/CPD certificate.

For any questions or concerns, please contact us at: education@kenes.com

Disclosure and Resolution of Personal Conflicts of Interest

In accordance with CME/CPD accreditation criteria and standards for commercial support to ensure balance, independence, objectivity, and scientific rigor, those in control of the educational content must disclose potential or actual conflicts of interest. Disclosure information is evaluated and conflicts of interest are resolved. Disclosure is made to participants before the activity. Participants will be asked on the evaluation to assess the objectivity and independence of the event.

View disclosure information here.

Industry Support Disclosure

This event is supported, in part, by funding from industry. All support is managed in strict accordance with CME/CPD accreditation criteria and standards for commercial support. Appropriate acknowledgment of all supporting organizations is made in the program guide, on the event website, and with signage during the event.

• View a list of all industry supporters here.
• View detailed programmes for all Industry Sessions here.

COMMITMENT TO THE HIGHEST STANDARDS IN CME/CPD

Kenes is committed to being a valuable and knowledgeable partner in the design and delivery of educationally strong, independent, transparent, and effective CME/CPD programs. Kenes is a proud member of the Good CME Practice Group (gCMEp), a member organization contributing to improving health outcomes by:

• Championing best practice in CME/CPD
• Maintaining and improving standards
• Mentoring and educating
• Working in collaboration with critical stakeholders

Membership in the Good CME Practice Group illustrates Kenes commitment to high standards and knowledgeable partnership with its clients in the design and delivery of medical events.